RETRACTION: Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma in Vivo and in Vitro.

International BR

Open source

DOI
10.1155/bmri/9802538
Published
2026
Container
BioMed research international
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/bmri/9802538,
  title = {RETRACTION: Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma in Vivo and in Vitro.},
  author = {International BR},
  year = {2026},
  journal = {BioMed research international},
  doi = {10.1155/bmri/9802538},
  url = {https://doi.org/10.1155/bmri/9802538}
}

RIS

TY  - JOUR
TI  - RETRACTION: Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma in Vivo and in Vitro.
AU  - International BR
PY  - 2026
JO  - BioMed research international
DO  - 10.1155/bmri/9802538
UR  - https://doi.org/10.1155/bmri/9802538
ER  - 

APA

BR, I. (2026). RETRACTION: Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma in Vivo and in Vitro.. BioMed research international. https://doi.org/10.1155/bmri/9802538

Source records